Tom Coburn actually said...
I think changing their charge from safety and efficacy to safety.
Context
Coburn suggests prioritizing safety over efficacy in FDA regulations.
07/13/2015
Coburn suggests prioritizing safety over efficacy in FDA regulations.
07/13/2015